mardi 12 juillet 2016

Onco Actu du 12 juillet 2016

1. Biologie

International collaboration to create new cancer models to accelerate research [National Cancer Institute]

Global initiative seeks 1,000 new cancer models [Nature News & Comment]

3.1.1 Tabac - e-cigs

E-cigarettes are used by teens who wouldn’t otherwise smoke, study finds [STAT]

E-cigarettes contribute to increased tobacco use by teens [Reuters]

4.2 Dép., diag. & prono. - Génome

Advancing precision diagnostics in oncology: VHIO to co-develop novel Next-Next Generation Sequencing [Vall d'Hebron Institute Oncology]

4.9 Dép., diag. & prono. - Sein

Myriad Announces Positive Results for an EndoPredict® Clinical Study Published in the Journal of the National Cancer Institute [Myriad]

5.12 Immunothérapies

Biomarkers for Immunotherapy: Results from ASCO 2016 [The OBR Blog]

5.2 Pharma

AbbVie Receives U.S. FDA Rare Pediatric Disease Designation for Investigational ABT-414 for the Treatment of a Type of Pediatric Brain Tumor known as Diffuse Intrinsic Pontine Glioma [AbbVie]

CytRx Sarcoma Drug Flops Late-Stage Clinical Trial [The Street]

CytRx Announces Initial Results of Phase 3 Trial of Aldoxorubicin in Patients with Second-Line Soft [PR Newswire]

5.2.1 Pharma - Partenariats

Sorrento nabs PD-1 deal with Servier [FierceBiotech]

5.2.3 Pharma - économie

Price Gouging and the Dangerous New Breed of Pharma Companies [Harvard Business Review]

5.4 Traitements - Economie

A Fair Plan For Fairer Drug Prices [Health Affairs]

6.10 Politiques

UK scientists dropped from EU projects because of post-Brexit funding fears [The Guardian]

6.10.1 Politiques (USA)

Obama blames high drug prices on companies too worried about profits [STAT]

Senate delays Cures bill, as window for major legislation narrows [STAT]

Next President Should Attack Drug Prices, Obama Says in JAMA [Bloomberg]

6.4 Médico-éco

A chain of for-profit cancer centers has been advertising more than all its competitors combined [STAT]

Cancer hospital advertising triples since 2005 [Reuters]

6.7.2 Applis

Dana-Farber, Fitbit partner for breast cancer study [FierceHealthcare]